HIV Medications for HIV Prevention: News & Research
- Shah Congratulates Researchers on PrEP Findings (July 15, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Where Do We Go From Here: Proof That a Pill Can Prevent HIV in Women and Men (July 14, 2011)
From Global Campaign for Microbicides
- TDF2 Study of Pre-Exposure Prophylaxis (PrEP) Among Heterosexual Men and Women in Botswana: Key Facts (July 14, 2011)
To read PDF, click here.
From U.S. Centers for Disease Control and Prevention
- Project Inform Urges Government Action Following the Positive Results of Two PrEP Studies in Heterosexual Men and Women (July 13, 2011)
From Project Inform
- Open-Label Extension of iPrEx HIV Pre-Exposure Prophylaxis (PrEP) Study Begins at 11 Sites in Six Countries (July 13, 2011)
iPrEx OLE to build on news that PrEP slows HIV infections significantly in both men who have sex with men and heterosexual women and men.
From iprexnews.com
- IAS 2011 Organizers Congratulate Researchers on New Data Showing PrEP Can Reduce Risk of HIV Infection Among Heterosexuals (July 13, 2011)
Trial's results to be presented fully in Rome next week highlight the strength of the conference's scientific programme and critical research advances occurring in HIV.
From International AIDS Society
- Two Major Studies Prove HIV Pre-Exposure Prophylaxis (PrEP) Works in Heterosexual Women and Men; Build on iPrEx Data Showing PrEP Reduces HIV Infections in Men Who Have Sex With Men (July 13, 2011)
From iprexnews.com
- Pivotal Study Finds That HIV Medications Are Highly Effective as Prophylaxis Against HIV Infection in Men and Women in Africa (July 13, 2011)
From University of Washington
 Two New Studies Support Use of PrEP for HIV Prevention Among Heterosexual Men and Women (July 13, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- CDC Trial and Another Major Study Find PrEP Can Reduce Risk of HIV Infection Among Heterosexuals (July 13, 2011)
CDC assessing data from all heterosexual trials to develop interim guidance for use.
From U.S. Centers for Disease Control and Prevention
- Forum in Chicago Explores Truvada's Use in HIV Prevention (June 22, 2011)
In The Windy City Times
- Joint Venture to Manufacture and Distribute Tenofovir Gel in Africa (June 16, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Large Trial of Tenofovir Gel for Women Set to Begin in South Africa (June 15, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 Study Finds That PReP Acceptance Depends on Cost Instead of Effectiveness: A Blog Entry by Candace Y.A. Montague (June 8, 2011)
"Using consumer marketing techniques, the study found that female sex workers, male-to-female transgender persons and men who have sex with men would be willing to take the pill if the cost to purchase it was low."
From TheBody.com
- Make Antiretroviral Therapy "Cornerstone" of HIV Prevention (June 8, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Ready to Launch: ADAPT Study Looks at Intermittent Dosing of PrEP (June 7, 2011)
From Project Inform
- Immediate Treatment for All of Us? PrEP for Everyone Else? (May 11, 2011)
From Black AIDS Institute
- HIV PJA Strategy Webinar Recap: FEM-PrEP Trial Closure, U.S. Pricing & Access Issues After iPrEx, & UN Update (April 21, 2011)
From HIV Prevention Justice Alliance
- San Francisco Chronicle: Researchers Should Not Give Up Search for HIV Prevention Pill (April 20, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Global Campaign for Microbicides Statement on the Discontinuation of the FEM-PrEP Trial (April 19, 2011)
From Global Campaign for Microbicides
- Researchers to Wind Down HIV Prevention Trial in Women After Interim Results Find Drug Not Offering Protection From HIV (April 19, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
|
Advertisement
|
Email
Glossary
